Cost-Utility Analysis of Eprosartan Compared to Enalapril in Primary Prevention and Nitrendipine in Secondary Prevention in Europe—The HEALTH ModelBengt Jönsson, Fernando Antoñanzas, Stephan Lüders et al.|Value in Health|2009Cited by 19